A physical sciences network characterization of non-tumorigenic and metastatic cells

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Agus, David B ^a   Alexander, Jenolyn F ^b   Arap, Wadih ^c   Ashili, Shashanka ^d   Aslan, Joseph E ^e,f   Austin, Robert H ^g   Backman, Vadim ^h   Bethel, Kelly J ⁱ   Bonneau, Richard ^j   Chen, Wei Chiang ^k   Chen Tanyolac, Chira ^l   Choi, Nathan C ^a   Curley, Steven A ^c   Dallas, Matthew ^k   Damania, Dhwanil ^h   Davies, Paul C W ^d   Decuzzi, Paolo ^b   Dickinson, Laura ^k   Estevez Salmeron, Luis ^l   Estrella, Veronica ^m   Ferrari, Mauro ^b   Fischbach, Claudia ⁿ   Foo, Jasmine ^o   Fraley, Stephanie I ^k   Frantz, Christian ^p   Fuhrmann, Alexander ^d   Gascard, Philippe ^l   Gatenby, Robert A ^m   Geng, Yue ⁿ   Gerecht, Sharon ^k   Gillies, Robert J ^m   Godin, Biana ^b   Grady, William M ^q,r   Greenfield, Alex ^j   Hemphill, Courtney ^d   Hempstead, Barbara L ^s   Hielscher, Abigail ^k   Hillis, W Daniel ^a,t   Holland, Eric C ^u   Ibrahim Hashim, Arig ^m   Jacks, Tyler ^v   Johnson, Roger H ^d   Joo, Ahyoung ^a   Katz, Jonathan E ^a   Kelbauskas, Laimonas ^d   Kesselman, Carl ^w   King, Michael R ⁿ   Konstantopoulos, Konstantinos ^k   Kraning Rush, Casey M ⁿ   Kuhn, Peter ^x   Kung, Kevin ^v   Kwee, Brian ⁿ   Lakins, Johnathon N ^p   Lambert, Guillaume ^g   Liao, David ^l   Licht, Jonathan D ^y   Liphardt, Jan T ^z,aa   Liu, Liyu ^g   Lloyd, Mark C ^m   Lyubimova, Anna ^v   Mallick, Parag ^a,ab   Marko, John ^ac   McCarty, Owen J T ^e,f   Meldrum, Deirdre R ^d   Michor, Franziska ^ad,ae   Mumenthaler, Shannon M ^a   Nandakumar, Vivek ^d   O'Halloran, Thomas V ^ac   Oh, Steve ^l   Pasqualini, Renata ^c   Paszek, Matthew J ^p   Philips, Kevin G ^e   Poultney, Christopher S ^j   Rana, Kuldeepsinh ⁿ   Reinhart King, Cynthia A ⁿ   Ros, Robert ^d   Semenza, Gregg L ^af   Senechal, Patti ^d   Shuler, Michael L ⁿ   Srinivasan, Srimeenakshi ^b   Staunton, Jack R ^d   Stypula, Yolanda ^h   Subramanian, Hariharan ^h   Tlsty, Thea D ^l   Tormoen, Garth W ^e   Tseng, Yiider ^k,ai   Van Oudenaarden, Alexander ^v   Verbridge, Scott S ^n,ah   Wan, Jenny C ^a   Weaver, Valerie M ^p,ag   Widom, Jonathan ^ac   Will, Christine ^y   Wirtz, Denis ^k   Wojtkowiak, Jonathan ^m   Wu, Pei Hsun ^k   more..

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d ARIZONA STATE UNIVERSITY   (United States)

^e Oregon Health and Science University Department of Biomedical Engineering   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g PRINCETON UNIVERSITY   (United States)

^h Northwestern University   (United States)

ⁱ SCRIPPS CLINIC   (United States)

^j NEW YORK UNIVERSITY   (United States)

^k Johns Hopkins University   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

ⁿ Cornell University   (United States)

^o UNIVERSITY OF MINNESOTA   (United States)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q Fred Hutchinson Cancer Research Center   (United States)

^r UNIVERSITY OF WASHINGTON   (United States)

^s WEILL CORNELL MEDICAL COLLEGE   (United States)

^t Applied Minds   (United States)

^u MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^v MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^w UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^x SCRIPPS RESEARCH INSTITUTE   (United States)

^y NORTHWESTERN UNIVERSITY   (United States)

^z UNIVERSITY OF CALIFORNIA   (United States)

^aa LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^ab STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ac NORTHWESTERN UNIVERSITY   (United States)

^ad DANA FARBER CANCER INSTITUTE   (United States)

^ae HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^af Institute for Cell Engineering   (United States)

^ag UNIVERSITY OF CALIFORNIA   (United States)

^ah VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^ai University of Florida   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER; TUMOR PROTEIN;

BIOLOGICAL MODEL; CELL MOTION; CELL SIZE; CELL SURVIVAL; COMPUTER SIMULATION; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; METASTASIS; PATHOLOGY; PATHOPHYSIOLOGY; TUMOR CELL LINE; ARTICLE;

CELL LINE, TUMOR; CELL MOVEMENT; CELL SIZE; CELL SURVIVAL; COMPUTER SIMULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84878282427     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01449     Document Type: Article

References (42)

1. Wirtz, D., Konstantopoulos, K. & Searson, P. C. The physics of cancer: the role of physical interactions and mechanical forces in metastasis. Nature reviews. Cancer 11, 512-522 (2011).
2. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
3. Davies, P. C., Demetrius, L. & Tuszynski, J. A. Cancer as a dynamical phase transition. Theor Biol Med Model 8, 30 (2011).
4. Debnath, J., Muthuswamy, S.K. & Brugge, J.S. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30, 256-268 (2003).
5. Cailleau, R., Mackay, B., Young, R. K. & Reeves, W. J., Jr. Tissue culture studies on pleural effusions from breast carcinoma patients. Cancer research 34, 801-809 (1974).
6. Subik, K. et al. The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines. Breast cancer: basic and clinical research 4, 35-41 (2010).
7. Akkiprik, M. et al. Dissection of signaling pathways in fourteen breast cancer cell lines using reverse-phase protein lysate microarray. Technology in cancer research & treatment 5, 543-551 (2006).
8. Prvulovic, I., Kardum-Skelin, I., Sustercic, D., Jakic-Razumovic, J. & Manojlovic, S. Morphometry of tumor cells in different grades and types of breast cancer. Collegium antropologicum 34, 99-103 (2010).
9. Nafe, R., Franz, K., Schlote, W. & Schneider, B. Morphology of tumor cell nuclei is significantly related with survival time of patients with glioblastomas. Clinical cancer research: an official journal of the American Association for Cancer Research 11, 2141-2148 (2005).
10. Kenny, P. A. et al. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Molecular oncology 1, 84-96 (2007).
11. Nandakumar, V., Kelbauskas, L., Johnson, R. & Meldrum, D. Quantitative characterization of preneoplastic progression using single-cell computed tomography and three-dimensional karyometry. Cytometry. Part A: the journal of the International Society for Analytical Cytology 79, 25-34(2011).
12. Damania, D. et al. Role of cytoskeleton in controlling the disorder strength of cellular nanoscale architecture. Biophysical journal 99, 989-996 (2010).
13. Butcher, D. T., Alliston, T. & Weaver, V. M. A tense situation: forcing tumour progression. Nature reviews. Cancer 9, 108-122 (2009).
14. Yeung, T. et al. Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. Cell motility and the cytoskeleton 60, 24-34 (2005).
15. Shain, K. H., Landowski, T. H. & Dalton, W. S. The tumor microenvironment as a determinant of cancer cell survival: a possible mechanism for de novo drug resistance. Current Opinion in Oncology 12, 557-563 (2000).
16. Sneath, R. J. & Mangham, D. C. The normal structure and function of CD44 and its role in neoplasia. Molecular pathology: MP 51, 191-200 (1998).
17. Brown, R.L. et al. CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. The Journal of clinical investigation 121, 1064-1074 (2011).
18. Zen, K. et al. CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration. PloS one 3, e1826 (2008).
19. Fraley, S. I. et al. A distinctive role for focal adhesion proteins in three-dimensional cell motility. Nature cell biology 12, 598-604 (2010).
20. Fraley, S. I., Feng, Y., Giri, A., Longmore, G. D. & Wirtz, D. Dimensional and temporal controls of three-dimensional cell migration by zyxin and binding partners. Nat Commun 3, 719 (2012).
21. Balzer, E. M. et al. Physical confinement alters tumor cell adhesion and migration phenotypes. FASEB J 26, 4045-4056 (2012).
22. Provenzano, P.P. et al. Collagen density promotes mammary tumor initiation and progression. BMC medicine 6, 11(2008).
23. Bresalier, R. S. et al. Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis. Gastroenterology 110, 1354-1367 (1996).
24. Lee, M. H. et al. Mismatch in mechanical and adhesive properties induces pulsating cancer cell migration in epithelial monolayer. Biophys J 102, 2731-2741 (2012).
25. Wirtz, D. Particle-Tracking Microrheology of Living Cells: Principles and Applications. Annual Review of Biophysics 38, 301-326 (2009).
26. Wu, P.-H. et al. High-throughput ballistic injection nanorheology to measure cell mechanics. Nat. Protocols 7, 155-170 (2012).
27. Egeblad, M. & Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nature reviews. Cancer 2, 161-174 (2002).
28. Erler, J. T. et al. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440, 1222-1226 (2006).
29. Sonnenberg, A. et al. Integrin alpha 6/beta 4 complex is located in hemidesmosomes, suggestinga major role in epidermal cell-basement membrane adhesion. The Journal of cell biology 113, 907-917 (1991).
30. Rüegg, C. et al. Role of integrin alpha 4 beta 7/alpha 4 beta P in lymphocyte adherence to fibronectin and VCAM-1 and in homotypic cell clustering. The Journal of cell biology 117, 179-189 (1992).
31. Lee, J. W., and Bae., S. H., Jeong, J. W., Kim, S. H. & Kim, K. W. Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Experimental & molecular medicine 36, 1-12 (2004).
32. Dews, M. et al. The Myc-miR-17 similarto 92 Axis Blunts TGF beta Signaling and Production of Multiple TGF beta-Dependent Antiangiogenic Factors. Cancer research 70, 8233-8246 (2010).
33. Giancotti, F. G. Targeting integrin beta 4 for cancer and anti-angiogenic therapy. Trends in pharmacological sciences 28, 506-511 (2007).
34. Erler, J. T. & Giaccia, A. J. Lysyl oxidase mediates hypoxic control of metastasis. Cancer research 66, 10238-10241 (2006).
35. Erler, J. T. et al. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440, 1222-1226 (2006).
36. Erler, J. T. et al. LOX is essential for hypoxia-induced metastasis. Radiotherapy and Oncology 78, S5-S5 (2006).
37. Bernstein, B. W. & Bamburg, J. R. A proposed mechanism for cell polarization with no external cues. Cell motility and the cytoskeleton 58, 96-103 (2004).
38. Jun Soo, K., Prabhakar, P., Vadim, B. & Igal, S. The influence of chromosome density variations on the increase in nuclear disorder strength in carcinogenesis. Physical biology 8, 015004 (2011).
39. Afify, A., Purnell, P. & Nguyen, L. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion. Exp Mol Pathol 86, 95-100 (2009).
40. Dickinson, L. E., and Ho., C. C., Wang, G. M., Stebe, K. J. & Gerecht, S. Functional surfaces for high-resolution analysis of cancer cell interactions on exogenous hyaluronic acid. Biomaterials 31, 5472-5478 (2010).
41. Guise, T. A. Parathyroid hormone-related protein and bone metastases. Cancer 80, 1572-1580 (1997).
42. Paszek, M. J. et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 8, 241-254.